AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27146108
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CC/IUI cycles without luteal-phase support)
Trial: 22348650
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behaviour therapy (ICBT) for 10 weeks
Trial: 24244406
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive behaviour therapy (GCBT) for 10 weeks
Trial: 18405149
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and moxibustion added to routine treatment, once daily for 10 days.
Trial: 16870951
Drug: α-adrenergic antagonists
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: α-adrenergic antagonists
Trial: 12573204
Drug: OM-85 BV
RxNorm normalized name: OM-85 BV
DrugBank: OM85 (DB16533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OM-85 BV (3.5 mg)
Trial: 1736694
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine 400 micrograms bolus followed by 40 micrograms/h infusion
Trial: 1736694
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine 800 micrograms bolus followed by 40 micrograms/h infusion
Trial: 1736694
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine (both doses) after bupivacaine
Trial: 31085043
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Osimertinib + Bevacizumab)
Trial: 22372795
Drug: OMP 20
RxNorm normalized name: OMP-54F28
DrugBank: Ipafricept (DB15045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMP 20 mg
Trial: 20928987
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (liquid iron and vitamins A and D)
Trial: 17993007
Drug: Xinnaoxin capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinnaoxin capsules
Trial: 15644006
Drug: 5 ml.h(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml.h(‐1) ropivacaine 0.2% (study group, n = 21)
Trial: 15644006
Drug: 5 ml.h(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml.h(‐1) saline (control group, n = 21)
Trial: 8872628
Drug: 700-ml infusion
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein, recombinant 0.24 MG/ML [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700-ml infusion of autologous erythrocytes (42% hematocrit)
Trial: 1732596
Drug: Intravesical epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical epirubicin administration
Trial: 30705097
Drug: Pegylated-asparaginase, intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated-asparaginase, intravenously at a dose of 2,500 IU/m2 on days 12 and 26
Trial: 28038881
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract plus diclofenac tablet
Trial: 28038881
Drug: Diclofenac tablet
RxNorm normalized name: diclofenac Oral Tablet
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac tablet alone
Trial: 12598214
Drug: In-laboratory determined
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-laboratory determined optimal pressure CPAP treatment
Trial: 10413395
Drug: General Internal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General Internal Medicine
Trial: 8585108
Drug: Lansoprazole 60
RxNorm normalized name: dexlansoprazole 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 60 mg once daily
Trial: 28655025
Drug: CAM2038 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAM2038 24 mg
Trial: 28655025
Drug: CAM2038 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAM2038 32 mg
Trial: 19785510
Drug: Atomoxetine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (0.5 to 1.2 mg/kg/day, uptitrated after two weeks)
Trial: 16923216
Drug: Freshly chopped
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Freshly chopped chilli blend (30 g/d; 55% cayenne chilli)
Trial: 8030582
Drug: Mepiphylline (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepiphylline (8 mg/kg/day divided in 3 doses for 10 days)
Trial: 8030582
Drug: Mepiphylline (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepiphylline (8 mg/kg/day)
Trial: 233825
Drug: Wheat fiber
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat fiber (36 g) added to diet for 3 weeks
Trial: 19583677
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg (oral dose)
Trial: 26706833
Drug: Exemestane therapy
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane therapy
Trial: 11032585
Drug: Tamoxifen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen therapy
Trial: 15534410
Drug: OP‐1 Putty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OP‐1 Putty (3.5 mg of OP‐1 per side)
Trial: 11535566
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (10 mg once a day)
Trial: 11535566
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid plus transdermal GTN
Trial: 11535566
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN plus placebo
Trial: 7845167
Drug: Omeprazole 3x40
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 3x40 mg + Amoxicillin 3x750 mg for 14 days
Trial: 7845167
Drug: Classical triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classical triple therapy containing bismuth and two antibiotics
Trial: 25708419
Drug: Probiotic preparation
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic preparation administered twice a day from ICU admission until 7 days or discharge from ICU.
Trial: 25708419
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no probiotics administered).
Trial: 20644484
Drug: 0.8 g
RxNorm normalized name: Alcohol 0.8 g in 1 mL TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g MnCl2 (n = 11)
Trial: 20644484
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g MnCl2 (n = 9)
Trial: 20644484
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses (0.8 g and 1.6 g MnCl2)
Trial: 3067116
Drug: Tianeptine (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tianeptine (37.5 mg per day)
Trial: 380915
Drug: Amitriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75 mg per day)
Trial: 29691148
Drug: Angiotensin receptor
RxNorm normalized name: Angiotensin receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor blocker (ARB) - valsartan
Trial: 29691148
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (ACEI) - ramipril
Trial: 28533054
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (2+1 doses at 3½-5-11 months or 6-8-11 months)
Trial: 28533054
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (3+1 doses at ages 2½-3½-5-11 months)
Trial: 28533054
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (2 catch-up doses administered 2 months apart)
Trial: 23846749
Drug: Hydromorphone titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone titration protocol (0.5 mg intravenous hydromorphone initially, with a second dose of 0.5 mg if requested)
Trial: 23846749
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (any dose of any intravenous opioid)
Trial: 21952034
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg vitamin B12 pill taken daily and routine PACAM food
Trial: 21952034
Drug: Placebo pill
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pill and milk-PACAM food fortified to provide 1 mg of vitamin B12
Trial: 21952034
Drug: Routine PACAM
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine PACAM food and placebo pill
Trial: 18978634
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication management plus relapse prevention cognitive-behavioral therapy (MM+CBT)
Trial: 18978634
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication management (MM)
Trial: 12729423
Drug: 10-day oral
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day oral doxycycline
Trial: 12729423
Drug: 20-day oral
RxNorm normalized name: ferrous fumarate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 20-day oral doxycycline
Trial: 12729423
Drug: Doxycycline +
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline + ceftriaxone (single intravenous dose)
Trial: 10934099
Drug: Inhaled PGE(2)
RxNorm normalized name: PGE-1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled PGE(2) (100 microgram)
Trial: 1525104
Drug: gemeprost alone
RxNorm normalized name: gemeprost
DrugBank: Gemeprost (DB08964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemeprost alone (1 mg every 6 h up to three doses)
Trial: 1525104
Drug: mifepristone (200‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mifepristone (200‐600 mg) followed 48 h later by a single dose of gemeprost (1 mg)
Trial: 28982101
Drug: Misoprostol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (2 tablets, 400 µg administered vaginally 12 hours before hysteroscopy)
Trial: 28982101
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 placebo tablets administered)
Trial: 26851398
Drug: Rolapitant (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolapitant (180 mg)
Trial: 22351940
Drug: ASP2151 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2151 (100 mg daily for 3 days)
Trial: 22351940
Drug: ASP2151 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2151 (200 mg daily for 3 days)
Trial: 22351940
Drug: ASP2151 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2151 (400 mg daily for 3 days)
Trial: 22351940
Drug: ASP2151 (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2151 (1200 mg as a single dose)
Trial: 27129009
Drug: Valacyclovir (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir (500 mg twice daily for 3 days)
Trial: 15907554
Drug: Caspofungin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin (50 mg/day after a 70 mg loading dose)
Trial: 15907554
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (0.6-1.0 mg/kg/day)
Trial: 14753637
Drug: Midazolam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (mean 12.5 mg)
Trial: 14753637
Drug: Diazepam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (mean 28.1 mg)
Trial: 11573659
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia with propofol and alfentanil
Trial: 7457638
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg of caffeine
Trial: 28722271
Drug: Liraglutide (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (0.6 to 1.8 mg over 24 weeks)
Trial: 27787672
Drug: Methylphenidate (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0.3 and 0.6 mg/kg)
Trial: 22982353
Drug: Contraceptive vaginal
RxNorm normalized name: VCF 4% Contraceptive Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive vaginal ring (CVR) delivering 150/15 μg Nestorone®/ethinyl estradiol (EE) daily
Trial: 22982353
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (OC) containing levonorgestrel and EE (150/30 μg)
Trial: 19383221
Drug: Valsartan/hydrochlorothiazide 80
RxNorm normalized name: valsartan/hydrochlorothiazide 80 mg-12.5 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/hydrochlorothiazide 80 mg/12.5 mg once daily
Trial: 24127952
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy or placebo
Trial: 9717596
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml lidocaine 1%
Trial: 9717596
Drug: 6 ml
RxNorm normalized name: ethanol 0.6 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 ml lidocaine 1%
Trial: 9717596
Drug: 8 ml
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 ml lidocaine 1%
Trial: 8122656
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg/day p.o.
Trial: 8122656
Drug: Fluconazole 50
RxNorm normalized name: fluconazole 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 50 mg/day p.o.
Trial: 15487320
Drug: No antifungal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antifungal therapy
Trial: 2549204
Drug: 500 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/m2 as a continuous intravenous (IV) infusion over 24 hours
Trial: 2549204
Drug: Five consecutive
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five consecutive daily 2-hour infusions each of 100 mg/m2
Trial: 16960528
Drug: Rabeprazole (RAB)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RAB) 20 mg x d(‐1)
Trial: 16960528
Drug: Sham esophageal
RxNorm normalized name: Cellspan Esophageal Implant
DrugBank: Cellspan Esophageal Implant (DB18688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham esophageal infusion (NG tube placed in the distal esophagus, no fluid)
Trial: 8471132
Drug: Debrisoquin (DBQ),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debrisoquin (DBQ), an inhibitor of monoamine oxidase
Trial: 6342335
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg daily
Trial: 3520794
Drug: Cimetidine 1600
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 1600 mg daily
Trial: 3520794
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg single-dose maintenance treatment
Trial: 29503145
Drug: Supplementation with
RxNorm normalized name: Similac For Supplementation with Iron Powder for Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementation with fish oil (1.7 g EPA + DHA/day), chocolate containing plant sterols (2.2 g/day), and green tea (two sachets/day) for 6 weeks
Trial: 29503145
Drug: Statin dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin dose reduction by 50% from weeks 6-12 after 6 weeks of standard therapy
Trial: 25352050
Drug: Tuina massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuina massage therapy (20 minutes, 4-step treatment protocol, 20 sessions over 4 weeks)
Trial: 25352050
Drug: Conventional analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional analgesics (specific daily dose of ibuprofen)
Trial: 20942292
Drug: Tuina massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuina massage therapy
Trial: 20738314
Drug: Physiological sex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological sex steroid replacement (pSSR)
Trial: 22343553
Drug: Standard sex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard sex steroid replacement (sSSR)
Trial: 17112304
Drug: Rimonabant 20mg
RxNorm normalized name: rimonabant
DrugBank: Rimonabant (DB06155)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Rimonabant 20mg once daily
Trial: 7286051
Drug: Chlorthalidone 50
RxNorm normalized name: chlorthalidone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 50 mg
Trial: 8862940
Drug: Chlorthalidone 50
RxNorm normalized name: chlorthalidone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 50 mg/triamterene 50 mg combination treatment
Trial: 1736500
Drug: Low-dose diethylstilbestrol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose diethylstilbestrol (DES) 1 mg daily
Trial: 6225627
Drug: 5 percent
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Lidocaine 5 Percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 percent benzoyl peroxide acetone gel for four weeks
Trial: 6225627
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent benzoyl peroxide acetone gel for an additional four weeks
Trial: 6225627
Drug: Placebo (acetone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (acetone gel vehicle)
Trial: 140786
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide acetone gel
Trial: 30131297
Drug: Inhaled vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled vancomycin
Trial: 29712666
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 (100,000 IU or 12,000 IU, n = 31 each) administered once monthly for 2 years
Trial: 29712666
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 (standard dose 12,000 IU) administered once monthly for 2 years
Trial: 27271717
Drug: Local cement
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local cement reinforcing antibacterial implant
Trial: 17398307
Drug: Methylprednisolone 20
RxNorm normalized name: methylprednisolone 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 20 mg intravenously, started 12 hours before extubation and every 4 hours until tube removal
Trial: 17398307
Drug: Methylprednisolone 20
RxNorm normalized name: methylprednisolone 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 20 mg intravenously
Trial: 16142596
Drug: Captopril 12.5
RxNorm normalized name: captopril 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 12.5 mg administered at night
Trial: 16142596
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered at night
Trial: 12142389
Drug: Aromatase inhibitor
RxNorm normalized name: Aromatase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitor (fadrozole)
Trial: 2288051
Drug: Ciprofloxacin 100
RxNorm normalized name: ciprofloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 100 mg orally, twice a day for 4 days
Trial: 2288051
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg orally, twice a day for 4 days
Trial: 7293935
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid preparation
Trial: 29967411
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (inactive treatment)
Trial: 23210068
Drug: Midazolam-dexamethasone (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam-dexamethasone (0.075 mg/kg + 0.05 mg/kg)
Trial: 7889885
Drug: Boron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boron supplementation (2.5 mg for 7 weeks)
Trial: 3300457
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 to 240 mg twice a day)
Trial: 3300457
Drug: Diltiazem (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (60 to 180 mg twice a day)
Trial: 3300457
Drug: Propranolol with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol with Hydrochlorothiazide (for patients not achieving treatment goal)